Springborn Laboratories Inc

Established in 1969, Springborn Smithers Laboratories is one of the leading global contract research organizations in the world that offers a range of ecotoxicology, environmental metabolism, analytical, and product chemistry and consultation services. Its clients include agricultural, industrial and specialty chemical producers and governmental agencies. The organization serves the pharmaceutical, veterinary and crop protection industries. Springborn Smithers Laboratories supports stewardship, ecological risk assessment, and effluent and hazardous waste testing programs. It is also responsible for the identification of contents in a technical grade product and composition investigation. The organization additionally participates in an avian toxicology program that concentrates on avian toxicity testing, nontarget organism pesticide exposure characterization and risk assessment. Springborn Smithers Laboratories has operations throughout Massachusetts, North Carolina and Ohio, as well as Switzerland.

Global Verification Network (GVN) is a full-service employment and tenant screening services provider based in Scituate, MA. Owned by TriHelix Investments, GVN offers background screening solutions for professional property managers, management companies, large corporations, independent rental owners, real estate agents, and applicants. With a focus on compliance and consumer privacy, GVN recently acquired key assets of MOCO, integrating their technology and personnel to enhance operational efficiencies and ensure legal compliance in today's regulatory environment. Through their proprietary software and commitment to protecting consumer rights, GVN aims to provide cost-effective and legally compliant screening services for clients in the employment and tenant screening industries.Generated from the website

ProThera Biologics, located in East Providence, RI, is pioneering a novel approach to treating severe inflammation associated with various diseases. The company focuses on developing a class of human plasma proteins that play a crucial role in modulating immune responses to restore health in patients suffering from life-threatening conditions. Central to their research are Interalpha Inhibitor Proteins (IAIPs), which are naturally occurring anti-inflammatory proteins with significant potential for treating severe inflammatory diseases. By harnessing these proteins, ProThera Biologics aims to create a first-in-class lifesaving medicine that can effectively stop and reverse the course of inflammation. Generated from the website